The analysis of pharmaceutical industry imports in South Africa reveals a relatively steady increase in value from 2013 to 2023, reaching $2.72 billion by 2023. The year-on-year growth for 2023 was 2.61%, representing a consistent upward trend, albeit with some fluctuations over the years. The compound annual growth rate (CAGR) over the past five years stood at 1.12%. Future forecasts from 2024 to 2028 show continued growth, with the forecasted 5-year CAGR at 1.85% and a projected increase of 9.61% in the total value.

Future trends to watch for:

Increases in demand for innovative pharmaceutical products driven by healthcare advancements.
Potential impacts of regulatory changes and trade policies.
Growth in local production capabilities which might reduce import reliance.
Improved healthcare infrastructure and access influencing demand.